Evidence map›Paper›PMID 32912829›Full record

ArticleResearch in social & administrative pharmacy : RSAP2021

Pharmacy practice research priorities during the COVID-19 pandemic: Recommendations of a panel of experts convened by FIP Pharmacy Practice Research Special Interest Group.

Dalia Dawoud, Aleda M H Chen, Charlotte Verner Rossing, Victoria Garcia-Cardenas, Anandi V Law, Parisa Aslani, Ian Bates, Zaheer-Ud-Din Babar, Shane Desselle

Abstract read
In one paragraph

Article in Research in social & administrative pharmacy : RSAP, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Pharmacy response to COVID-19: lessons learnt from Canada.Journal of pharmaceutical policy and practice · 2020
    Article
  13. Bloom Program pharmacy teams' experiences providing mental health services during the COVID-19 pandemic.Canadian pharmacists journal : CPJ = Revue des pharmaciens du Canada : RPC
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Dalia DawoudCairo University, Faculty of Pharmacy, Clinical Pharmacy Department, Cairo, Egypt. Electronic address: ddawoud@gmail.com.
Aleda M H ChenSchool of Pharmacy, Cedarville University, Cedarville, OH, USA.
Charlotte Verner RossingPharmakon, Danish College of Pharmacy Practice, Copenhagen, Denmark.
Victoria Garcia-CardenasUniversity of Technology Sydney, Sydney, Australia.
Anandi V LawCollege of Pharmacy, Western University of Health Sciences, Pomona, CA, United States.
Parisa AslaniThe University of Sydney Pharmacy School, Faculty of Medicine and Health, Sydney, NSW, Australia.
Ian BatesUniversity College London, School of Pharmacy, London, United Kingdom.
Zaheer-Ud-Din BabarDepartment of Pharmacy, School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom.
Shane DesselleTouro University California, Vallejo, CA, United States.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Across the globe, pharmacists on the frontline continue to fight COVID-19 and its continuously evolving physical, mental, and economic consequences armed by their knowledge, professionalism, and dedication. Their need for credible scientific evidence to inform their practice has never been more urgent. Despite the exponentially increasing number of publications since the start of the pandemic, questions remain unanswered, and more are created, than have been resolved by the increasing number of publications. A panel of leading journal editors was convened by the International Pharmaceutical Federation (FIP) Pharmacy Practice Research Special Interest Group to discuss the current status of COVID-19 related research, provide their recommendations, and identify focal points for pharmacy practice, social pharmacy, and education research moving forward. Key priorities identified spanned a wide range of topics, reflecting the need for good quality research to inform practice and education. The panel insisted that a foundation in theory and use of rigorous methods should continue forming the basis of inquiry and its resultant papers, regardless of topic area. From assessing the clinical and cost effectiveness of COVID-19 therapies and vaccines to assessing different models of pharmaceutical services and education delivery, these priorities will ensure that our practice is informed by the best quality scientific evidence at this very challenging time.

Indexed as

COVID-19HumansPharmaceutical ServicesPharmacistsPharmacy ResearchProfessionalismProfessional RoleCOVID-19Pharmacy educationPharmacy practiceResearch

Identifiers

PMID32912829
PMCPMC7448778

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.